Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma

In melanoma patients, serum levels of YKL-40, S-100B and LDH correlate significantly with the stage of disease. In stage IV melanoma, S100-B significantly correlates with treatment response and survival and is superior to LDH and YKL-40.